The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

Código QR

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

Małgorzata Urban-Kowalczyk,1 Magdalena Kotlicka-Antczak,1 Dominik Strzelecki,1 Ewa Rudecka,2,3 Janusz Śmigielski4 1Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland; 2Babiński Memorial Hospital in Łódź, Łódź, Poland;...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	β-endorphin dopamine opioid peptides schizophrenia Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f22783bc95984fbd9e00099ac62bebdb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2021)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2016)

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk M, et al.
Publicado: (2019)

INDICATORS OF CYTOKINE ACTIVITY AND BETA-ENDORPHIN PRODUCTION LEVEL IN ARTERIAL HYPERTENSION ASSOCIATED WITH ASTHENIC/NEUROTIC DISORDERS IN YOUNG MEN EMPLOYED IN STRESSFUL PROFESSIONS
por: A. V. Gertsev, et al.
Publicado: (2017)

THE IMPACT OF LAVENDER AROMATHERAPY ON PAIN INTENSITY AND BETA-ENDORPHIN LEVELS IN POST-CAESAREAN MOTHERS
por: Yohana Putri Apryanti, et al.
Publicado: (2017)

IMPACT OF ANXIETY AND DEPRESSIVE DISORDERS ON THE NEUROPEPTIDE-CYTOKINE STATUS OF IMMUNE SYSTEM IN VARIOUS VARIANTS OF THE CLINICAL COURSE OF CHRONIC ISCHEMIC HEART DISEASE
por: A. V. Gertsev, et al.
Publicado: (2019)

Effects of Compost-Bedded Pack Barn on Circulating Cortisol and Beta-Endorphins in Dairy Cows: A Case Study
por: Rosangela Odore, et al.
Publicado: (2021)

CHARACTERISTICS OF NEUROPEPTIDE-CYTOKINE IMMUNITY LINKS IN PATIENTS WITH COMBINED CARDIOVASCULAR PATHOLOGY, PROCEEDING WITH ANXIETY/DEPRESSION DISORDER
por: A. V. Gertsev, et al.
Publicado: (2018)

CHARACTERISTIC INFLUENCE OF PULSE ELECTROTHERAPY (ELECTRICAL SLEEP) AT A NEUROPEPTIDE-CYTOKINE LINKS IN ARTERIAL HYPERTENSION ACCOMPANIED BY A ASTHENONEUROTIC DISTURBANCES IN YOUNG MEN EMPLOYED IN STRESSFUL PROFESSIONS
por: A. V. Gertsev, et al.
Publicado: (2018)

Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia
por: Dariusz Juchnowicz, et al.
Publicado: (2021)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts RJ, et al.
Publicado: (2016)

Long-lasting extrapyramidal symptoms after multiple injections of paliperidone palmitate to treat schizophrenia
por: Takada R, et al.
Publicado: (2018)

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study
por: Strzelecki D, et al.
Publicado: (2015)

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis
por: He HR, et al.
Publicado: (2016)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
por: Patrycja Redkiewicz, et al.
Publicado: (2021)

No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis
por: Qi XL, et al.
Publicado: (2017)

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
por: L. A. Ivanova, et al.
Publicado: (2019)

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
por: Han JY, et al.
Publicado: (2017)

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
por: Urban-Kowalczyk M, et al.
Publicado: (2015)

Schizophrenia research and treatment

Schizophrenia research
Publicado: (1988)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel T
Publicado: (2021)

Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
por: Huang Y, et al.
Publicado: (2017)

Sex differences in the course of schizophrenia across diverse regions of the world
por: Novick D, et al.
Publicado: (2016)

Clinical schizophrenia & related psychoses
Publicado: (2007)

Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
por: Daoust R, et al.
Publicado: (2020)

Opioid antagonism modulates wanting-related frontostriatal connectivity
por: Alexander Soutschek, et al.
Publicado: (2021)

Aripiprazole for late-life schizophrenia
por: Jeffrey Rado, et al.
Publicado: (2010)

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

A Short Course Computer-assisted Cognitive Remediation in Patients with Schizophrenia Spectrum Disorders: A Randomized Clinical Trial
por: Samira Hatami, et al.
Publicado: (2021)

Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency
por: Joseph V. Pergolizzi, et al.
Publicado: (2021)

Exploring Influences on Theory of Mind Impairment in Opioid Dependent Patients
por: Katharina Eidenmueller, et al.
Publicado: (2021)

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease
por: Zeng LH, et al.
Publicado: (2013)

Self-perception of mental illness, and subjective and objective cognitive functioning in people with schizophrenia
por: Chuang SP, et al.
Publicado: (2019)

Effects of Chronic Social Defeat Stress on Behavior and Dopamine Receptors in Adolescent Mice With 6-Hydroxydopamine Lesions of the Medial Prefrontal Cortex
por: Tong Zhao, et al.
Publicado: (2021)

The effect of transcranial direct current stimulation on beta-endorphin in older adults with knee osteoarthritis pain
por: Hyochol Ahn, et al.
Publicado: (2021)

Teaching Pain Management in Serious Illness in the Era of the Opioid Epidemic: A Team-Based Intervention
por: Alana Sagin, et al.
Publicado: (2020)

Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia
por: Kadasah S, et al.
Publicado: (2017)